U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163611) titled 'Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Stud... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163039) titled 'The Effect of Dual Task Training on Cognitive in Alzheimer's Disease' on Aug. 21. Brief S... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162896) titled 'Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis'... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163962) titled 'THE B-BABIES STUDY: An Observational Study of Group B Vitamins in Preterm Infants' on June... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163650) titled 'Randomized Controlled Trial Evaluating Anti-Obesity Medications 6 Months After Metabolic S... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162870) titled 'Idiopathic Pulmonary Fibrosis Cohort of TCM' on June 29. Brief Summary: This study, based... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07161869) titled 'Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)' on Aug. 28. Bri... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163273) titled 'Monthly Alternating NALIRIFOX and GnP in the First-Line Setting' on July 14. Brief Summar... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163507) titled 'Immune Response Under Immunotherapy in Lung Cancer: Study of Sputum Samples' on Sept. 01. ... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163624) titled 'UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study' on Sept. 01. Brief Summary: T... Read More